Editorial: Antivirulence Drugs Against Bacterial Infections

FRONTIERS IN MICROBIOLOGY

FRONTIERS MEDIA SA

1. Subprograma Miguel Servet Tipo I, Instituto de Salud Carlos III of Spain [CP15/00132]
2. Proyectos de Investigacion en Salud, Instituto de Salud Carlos III [PI19/01009]
3. PRIN [20177J5Y3P]
4. Excellence Departments grant from the Italian Ministry of Education, University and Research [314337, 232/2016]
5. National Program Office
6. Vaccines and Emerging Infection Research Initiative at National Research Council Canada